BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 03, 2004
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Genentech Inc.

(DNA), South San Francisco, Calif.

OSI Pharmaceuticals Inc.

(OSIP), Melville, N.Y.

Business: Cancer

Lazard analyst Joel Sendek increased his price targets for OSIP and DNA to $98 and $144 from $42 and $124, respectively. Sendek also...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >